Skip to content
Open access

Peripheral Inflammatory Biomarkers in Chronic Autoimmune-Associated Epilepsy: An Exploratory Case–Control Study

Sep 2026 · Biomolecules · Vol 16 · 0 citations · 40 references
Medicine

TL;DR

Lower plasma IL-12 levels may reflect a peripheral immune association in chronic AAE, and this findings are exploratory and hypothesis-generating and require replication in larger, prospectively recruited, independent cohorts.

Abstract

Background: Autoimmune-associated epilepsy (AAE) was recognized by the ILAE in 2017 as a distinct etiological category driven by chronic neuroinflammation rather than structural or genetic mechanisms. Reliable peripheral circulating inflammatory biomarkers to distinguish AAE from structural epilepsy remain lacking, potentially limiting timely recognition and evaluation for immunotherapy. In this observational case–control exploratory single-center study, plasma levels of 20 pro-inflammatory and 3 anti-inflammatory biomarkers, plus cerebrospinal fluid neurofilament light chain and HMGB1, were measured in 18 AAE patients, 33 non-autoimmune epilepsy patients and 16 healthy controls. AAE was defined using Dubey’s APE2-based criteria. Univariate comparisons, ROC analysis, and binary logistic regression were performed. Results: Among the 25 biomarkers analyzed, plasma IL-12 showed the lowest nominal p-value in the global between-group comparison (p=0.038), with lower concentrations in AAE. However, no biomarker remained statistically significant after Benjamini–Hochberg false discovery rate correction (IL-12 q=0.366). ROC analysis yielded an AUC of 0.670 for IL-12 alone for distinguishing AAE from the remainder of the cohort. In an exploratory primary multivariable model including plasma IL-12, drug-resistant epilepsy (DRE) status, and EEG pattern, the apparent in-sample discriminative performance was higher than that of IL-12 alone (AUC = 0.771; 95% CI, 0.635–0.892). Discussion: Lower plasma IL-12 levels may reflect a peripheral immune association in chronic AAE. These findings are exploratory and hypothesis-generating and require replication in larger, prospectively recruited, independent cohorts.

Read PDF

Similar papers

Open access Aug 2026

Total cerebrospinal fluid IgA as a candidate adjunctive biomarker associated with autoimmune encephalitis: a retrospective case–control study

Background Autoimmune encephalitis (AE) is a rare but severe immune-mediated disease of the central nervous system. Early diagnosis remains challenging, and total cerebrospinal fluid (CSF) IgA is a routinely measurable parameter. However, its association with AE and its potential value as a candidate adjunctive biomark...

Dong-Xing Wang, Ling Tan, Peng-Zhu Yang et al. · 0 citations
Open access Aug 2026

Chronic low-grade inflammation, genetic susceptibility, and the risk of multiple sclerosis: a prospective cohort study

The association of LGI with incident MS risk and MS-related brain structural measures in a large prospective cohort suggests that peripheral inflammation may serve as a potential marker for identifying individuals at elevated MS risk, warranting further investigation in interventional studies.

Yi-Zhou Cai, Yu-Jia Bao, Yong-Xuan Li et al. · 0 citations
Open access Sep 2026

Comparative analysis of six inflammatory markers in epilepsy severity: SIRI shows the strongest association

Objective biomarkers for assessing epilepsy severity are lacking. This study compared the ability to identify higher NHS3 scores using six peripheral blood parameters — including the systemic inflammatory response index (SIRI) and mean platelet volume (MPV) — and evaluated whether combining SIRI and MPV improves...

Jun-Feng Li, Xiang-Yu Li, Gun-Yi Dong et al. · 0 citations
Open access Sep 2026

Comparative Analysis of IL-18 Expression Across Therapeutic Modalities in Multiple Sclerosis

Background: Multiple sclerosis represents a chronic autoimmune pathology associated with immune-related demyelination and neuro inflammation in the central nervous system. Recently, interleukin-18 appears to represent one of the major cytokines among other inflammatory mediators, responsible for innate and adaptive imm...

Zahraa Mazin Zyara, A. E. Mahmood, Gheyath Abd Ali Shallal · 0 citations
Open access Sep 2026

842. Elevated systemic immune-inflammation index in DSM-5 Schizophrenia - A controlled case–control study

Abstract Background Low-grade systemic inflammation has been increasingly implicated in the pathophysiology of schizophrenia. Peripheral immune activation (characterized by relative neutrophilia, lymphocyte reduction, and platelet activation) has been associated with cytokine-mediated pathways (e.g., IL-6, TNF-α) and i...

A.-G. Zanfir · 0 citations
Open access Sep 2026

Predictive Value of Combined Serological Indicators for Cognitive Dysfunction in Patients with Systemic Lupus Erythematosus

Cognitive dysfunction (CD) is a common neuropsychiatric manifestation of systemic lupus erythematosus (SLE), but its early identification lacks objective serological markers. This study aimed to explore the predictive value of combined serum interleukin-6 (IL-6), intercellular adhesion molecule-1 (ICAM-1), and neurofil...

Gui-Min Zheng, Lei Wang, Jing-Jing Cao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.